rdf:type |
|
lifeskim:mentions |
umls-concept:C0007320,
umls-concept:C0013216,
umls-concept:C0032854,
umls-concept:C0035647,
umls-concept:C0085973,
umls-concept:C0183683,
umls-concept:C0205851,
umls-concept:C0344211,
umls-concept:C0439659,
umls-concept:C1171411,
umls-concept:C1317973,
umls-concept:C1518999,
umls-concept:C1521721,
umls-concept:C1561558,
umls-concept:C2348628
|
pubmed:issue |
1
|
pubmed:dateCreated |
2002-4-4
|
pubmed:abstractText |
A variety of regimens of high-dose chemotherapy with hematopoietic stem cell support for poor risk germ cell tumors have been established. However, a series of chemotherapy steps carried out prior to the harvest sometimes leads to an insufficient number of peripheral blood stem cells. Here, we report a case of a patient who successfully underwent high-dose chemotherapy for the treatment of poor risk extragonadal germ cell tumor by receiving peripheral blood stem cell transplantation donated from his genomically identical twin brother.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0368-2811
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
33-4
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:11932361-Adult,
pubmed-meshheading:11932361-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11932361-Cisplatin,
pubmed-meshheading:11932361-Etoposide,
pubmed-meshheading:11932361-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11932361-Humans,
pubmed-meshheading:11932361-Ifosfamide,
pubmed-meshheading:11932361-Lymphatic Metastasis,
pubmed-meshheading:11932361-Male,
pubmed-meshheading:11932361-Neoplasms, Germ Cell and Embryonal,
pubmed-meshheading:11932361-Risk Factors,
pubmed-meshheading:11932361-Transplantation, Isogeneic,
pubmed-meshheading:11932361-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Dose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report.
|
pubmed:affiliation |
Department of Urology, Kyoto University Hospital, Kyoto, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|